Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-19T12:37:07.843Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuropsychiatric symptoms and immune activation in patients with genital herpes

Published online by Cambridge University Press:  24 June 2014

Uté Vollmer-Conna ,
Marcus Chen ,
Andrew Lloyd  and
Basil Donovan
Uté Vollmer-Conna*
Affiliation:
School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia
Marcus Chen
Affiliation:
Sydney Sexual Health Centre at the Sydney Hospital, Sydney, New South Wales, Australia
Andrew Lloyd
Affiliation:
Inflammatory Diseases Research Unit, School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia
Basil Donovan
Affiliation:
Sydney Sexual Health Centre at the Sydney Hospital, Sydney, New South Wales, Australia The National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, New South Wales, Australia
*
Dr Ute Vollmer-Conna, Department of Human Behaviour, School of Psychiatry, University of New South Wales, Sydney, NSW 2052, Australia. Tel: +61 (02) 9385 2945; Fax: +61 (02) 9385 2944; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Neuropsychiatric disturbances are common among patients with genital herpes simplex virus (HSV) infection. To date, no studies have examined the possible role of immune activation in the aetiology of these disturbances. The aim of this study was to examine the relationship between markers of immune activation and measures of emotional and somatic dysfunction among patients with symptomatic genital herpes.

Methods:

Twenty-two patients with documented genital herpes were assessed when herpetic lesions were present and when they were not. Each assessment included a clinical examination, self-reported symptom measures as well as a blood and urine collection. Markers of immune activation [neopterin and interleukin (IL)-6] in serum and urine were quantified by enzyme-linked immunoassay. These measures were also obtained from a group of healthy control subjects.

Results:

Urine, but not serum, levels of neopterin and IL-6 correlated significantly with measures of reported psychological distress and fatigue. These associations were not confined to periods of overt clinical lesions.

Conclusions:

HSV-related neuropsychiatric morbidity correlates selectively with regional, but not systemic, measures of immune activation. We hypothesise that communication between the local inflammatory site in the pelvis and the brain occurs through autonomic afferent pathways.

Keywords

genital herpesherpes simplex virusimmune activationneuropsychiatric disturbance
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 20 , Issue 3 , June 2008 , pp. 145 - 151
Copyright
Copyright © 2008 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cunningham, AL, Mikloska, Z. The Holy Grail: Immune control of human herpes simplex virus infection and disease. Herpes 2001;8(Suppl 1):6A–10A. Google ScholarPubMed
Auslander, BA, Biro, FM, Rosenthal, SL. Genital herpes in adolescents. Seminar Pediatr Infect Dis 2005;16:24–30. CrossRefGoogle ScholarPubMed
Simmons, A. Clinical manifestations and treatment considerations of herpes simplex virus infection. J Infec Dis 2002;186:S71–S77. CrossRefGoogle ScholarPubMed
Parr, MB, Parr, EL. Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extra neural sites. J Neurovirol 2003;9:594–602. CrossRefGoogle Scholar
Duerst, RJ, Morrison, LA. Innate immunity to herpes simplex virus type 2. Viral Immunol 2003;16:475–490. CrossRefGoogle ScholarPubMed
Wald, A, Zeh, J, Selke, S, Ashley, RL, Corey, L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333:770–775. CrossRefGoogle ScholarPubMed
Carney, O, Ross, E, Bunker, C, Ikkos, G, Mindel, A. A prospective study of the psychological impact on patients with a first episode of genital herpes. Genitourin Med 1994;70:40–45. Google ScholarPubMed
Grreen, J, Kocsis, A. Psychological factors in recurrent genital herpes. Genitourin Med 1997;73:253–258. Google Scholar
Werther, J. Die psychogenen Dermatosen. Z Arztl Fortbild 1929;26:341–346. Google Scholar
Goldmeier, D, Johnson, A, Jeffries, Det al. Psychological aspects of recurrences of genital herpes. J Psychosom Res 1986;30:601–608. CrossRefGoogle ScholarPubMed
Mclarnon, LD, Kaloupek, DG. Psychological investigation of genital herpes recurrence: prospective assessment and cognitive behavioural intervention for a chronic physical disorder. Health Psychol 1988;7:231–249. CrossRefGoogle ScholarPubMed
Kemeny, ME, Cohen, F, ZeEgans, LS, Conant, MA. Psychological and immunological predictors of genital herpes recurrence. Psychosom Med 1989;51:195–208. CrossRefGoogle ScholarPubMed
Dalkvist, J, Wahlin, TB, Bartsch, E, Forsbeck, M.Herpes simplex and mood: a prospective study. Psychosom Med 1995;57:127–137. CrossRefGoogle ScholarPubMed
Cohen, F, Kemeny, ME, Kearney, KA, Zegans, LS, Neuhaos, JM, Conant, MA. Persistent stress as a predictor of genital herpes recurrence. Arch Intern Med 1999;159:2430–2434. CrossRefGoogle ScholarPubMed
Vollmer-Conna, U. Acute sickness behaviour: an immune system-to-brain communication? Psychol Med 2001;31:761–767. CrossRefGoogle Scholar
Hart, B. Biological basis of the behaviour of sick animals. Neurosci Biobehav Rev 1988;12:123–137. CrossRefGoogle ScholarPubMed
Maier, SF, Watkins, LR. Bidirectional communication between the brain and the immune system: implications for behaviour. Anim Behav 1999;75:741–751. CrossRefGoogle Scholar
Kelley, KW, Bluthe, RM, Dantzer, Ret al. Cytokine-induced sickness behavior. Brain Behav Immun 2003;17(Suppl 1):S112–S118. CrossRefGoogle ScholarPubMed
Vollmer-Conna, U, Fazoui, C, Cameron, Bet al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 2004;34:1289–1297. CrossRefGoogle ScholarPubMed
Cowan, ML, Maxwell, JD. Treatment of hepatitis C virus infection in intravenous drug users. Acta Neuropsychiatr 2006;18:183–192. CrossRefGoogle ScholarPubMed
Vandvik, PO, Lyndersen, S, Farup, PG. Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol 2006;41:650–656. CrossRefGoogle ScholarPubMed
Vollmeer-Conna, U, Lloyd, A, Hickie, I, Wakefield, D. Chronic fatigue syndrome: an immunological perspective. Aust N Z J Psychiatry 1998;32:523–527. CrossRefGoogle Scholar
Capuron, L, Hauser, P, Hinze-Selch, D, Miller, A, Neveu, PJ. Treatment of cytokine-induced depression. Brain Behav Immun 2002;16:575–580. CrossRefGoogle ScholarPubMed
Dantzer, R. Somatisation: a psychoneuroimmune perspective. Psychoneuroendocrinology 2005;30:947–952. CrossRefGoogle Scholar
Fuchs, D, Weiss, G, Reibnegger, G, Wachter, H. The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 1992;29:307–341. CrossRefGoogle ScholarPubMed
Fuchs, D, Weiss, G, Wachter, H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allergy Immunol 1993;101:1–6. CrossRefGoogle ScholarPubMed
Papanicolaou, DA. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127–137. CrossRefGoogle ScholarPubMed
Hickie, IB, Davenport, TA, Hadzi-Pavlovic, Det al. Development of a simple screening tool for common mental disorders in general practice. Med J 2001;175:S10–S17. Google ScholarPubMed
McNair, DM, Lorr, M, Droppleman, LF. EdITS manual for the Profile of Mood States. San Diego: EdITS/ Educational and Industrial Testing Service, 1992. Google Scholar
Von Korff, M, Ustun, TB, Ormel, J, Kaplan, I, Simon, GE. Self-report disability in an international primary care study of psychological illness. J Clin Epidemiol 1996;49:297–303. CrossRefGoogle Scholar
Kayama, F, Yoshida, T, Kodama, Y, Matsui, T, Matheson, JM, Luster, MI. Pro-inflammatory cytokines and interleukin 6 in the renal response to bacterial endotoxin. Cytokine 1997;9:688–695. CrossRefGoogle ScholarPubMed
Benson, M, Jodal, U, Aandreasson, A, Karlsson, A, Rydberg Svanborg, C. Interleukin 6 response to urinary tract infection in childhood. Pediatr Infect Dis 1994;13:612–616. CrossRefGoogle ScholarPubMed
Fleck, M, Podlech, J, Weise, K, Muntefering, H, Falke, D. Pathogenesis of HSC-1/2 induced vaginitis/vulvitis of the mouse: dependence on lesions on genetic properties of the virus and analysis of pathohistology. Arch Virol 1993;129:35–51. CrossRefGoogle Scholar
Corey, L, Spear, PG. Infections with herpes simplex viruses. Part 1. N Engl J Med 1986a;314:686–691. CrossRefGoogle Scholar
Corey, L, Spear, PG. Infections with herpes simplex viruses. Part 2. N Engl J Med 1986b;314:749–757. CrossRefGoogle Scholar
Goehler, LE, Gaykema, RP, Hansen, MK, Anderson, K, Maier, SF, Watkins, LR. Vagal immune-to-brain communication: a visceral chemosensory pathway. Autonom Neurosci 2000;85:49–59. CrossRefGoogle ScholarPubMed
Gidron, Y, Perry, H, Glennie, M. Does the vagus nerve inform the brain about preclinical tumours and modulate them? Lancet Oncol 2005;6:245–248. CrossRefGoogle Scholar
Craig, AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nature 2002;3:655–666. Google Scholar
Craig, AD. Interoception: the sense of physiological condition of the body. Curr Opin Neurobiol 2003;13:500–505. CrossRefGoogle Scholar